litlas
Log inCreate account

Mark A. Dawson

Active 1999–2025

78
Papers
17,907
Citations
52
h-index
75
i10-index

Citations

Citations per year for Mark A. Dawson1948: 1 citations1969: 1 citations1993: 1 citations1999: 1 citations2001: 2 citations2002: 3 citations2004: 2 citations2008: 5 citations2009: 11 citations2010: 46 citations2011: 54 citations2012: 105 citations2013: 176 citations2014: 222 citations2015: 217 citations2016: 182 citations2017: 210 citations2018: 215 citations2019: 769 citations2020: 883 citations2021: 1,041 citations2022: 879 citations2023: 695 citations2024: 1,170 citations2025: 649 citations2026: 22 citations1949–1968: no citations, so these years are not shown1970–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown2000: no citations, so this year is not shown2003: no citations, so this year is not shown2005–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,775 citing papers, 26.9% of this breakdownChina: 2,082 citing papers, 20.2% of this breakdownUnited Kingdom: 707 citing papers, 6.9% of this breakdownGermany: 577 citing papers, 5.6% of this breakdownAustralia: 410 citing papers, 4% of this breakdownFrance: 355 citing papers, 3.4% of this breakdownItaly: 354 citing papers, 3.4% of this breakdownCanada: 260 citing papers, 2.5% of this breakdownJapan: 230 citing papers, 2.2% of this breakdownSpain: 222 citing papers, 2.2% of this breakdownNetherlands: 168 citing papers, 1.6% of this breakdownIndia: 154 citing papers, 1.5% of this breakdown
0%26.9%Other 19.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology57.5%
  • Medicine31.2%
  • Immunology and Microbiology5.6%
  • Agricultural and Biological Sciences1.2%
  • Chemistry1.1%
  • Engineering0.8%
  • Other2.6%

Topics

  • Epigenetics and DNA Methylation7.6%
  • Protein Degradation and Inhibitors6.7%
  • Histone Deacetylase Inhibitors Research4.4%
  • RNA modifications and cancer4%
  • Ubiquitin and proteasome pathways3%
  • Cancer-related gene regulation2.9%
  • Other71.4%

Coauthors

All papers

Open in search
  1. Cancer Epigenetics: From Mechanism to Therapy

    Authors: Mark A. Dawson, Tony Kouzarides - Cell 2012 cited by 3,240

  2. Targeting the epigenetic regulation of antitumour immunity

    Authors: Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, Ricky W. Johnstone - Nature Reviews Drug Discovery 2020 cited by 620

  3. Non-genetic mechanisms of therapeutic resistance in cancer

    Authors: Jean‐Christophe Marine, Sarah‐Jane Dawson, Mark A. Dawson - Nature reviews. Cancer 2020 cited by 615

  4. An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

    Authors: Marian L. Burr, Christina E. Sparbier, Kah Lok Chan, Yih-Chih Chan, Ariena Kersbergen, Enid Y.N. Lam, Elizabeth Azidis-Yates, Dane Vassiliadis, Charles C. Bell, Omer Gilan, Susan Jackson, Lavinia Tan, Stephen Q. Wong, Sebastian Hollizeck, Ewa M. Michalak, Hannah V. Siddle, Michael T. McCabe, Rab K. Prinjha, Glen Guerra, Benjamin Solomon, Shahneen Sandhu, Sarah‐Jane Dawson, Paul A. Beavis, Richard W. Tothill, Carleen Cullinane, Paul J. Lehner, Kate D. Sutherland, Mark A. Dawson - Cancer Cell 2019 cited by 642

  5. A druggable copper-signalling pathway that drives inflammation

    Authors: Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, Antoine Versini, Arnaud Mansart, Fabien Sindikubwabo, Leeroy Baron, Laila Emam, Pierre Gestraud, G. Dan Pantoş, Vincent Gandon, Christine Gaillet, Ting‐Di Wu, Florent Dingli, Damarys Loew, Sylvain Baulande, Sylvère Durand, Valentin Sencio, Cyril Robil, François Trottein, David Péricat, Emmanuelle Näser, Céline Cougoule, Étienne Meunier, Anne-Laure Bègue, Hélène Salmon, Nicolas Manel, Alain Puisieux, Sarah Watson, Mark A. Dawson, Nicolas Servant, Guido Kroemer, Djillali Annane, Raphaël Rodriguez - Nature 2023 cited by 311

  6. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

    Authors: Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan, James C. Williamson, Katherine Woods, Paul A. Beavis, Enid Y.N. Lam, Melissa A. Henderson, Charles C. Bell, Sabine Stolzenburg, Omer Gilan, Stuart Bloor, Tahereh Noori, David W. Morgens, Michael C. Bassik, Paul J. Neeson, Andreas Behren, Phillip K. Darcy, Sarah‐Jane Dawson, Ilia Voskoboinik, Joseph A. Trapani, Jonathan Cebon, Paul J. Lehner, Mark A. Dawson - Nature 2017 cited by 969

  7. The roles of DNA, RNA and histone methylation in ageing and cancer

    Authors: Ewa M. Michalak, Marian L. Burr, Andrew J. Bannister, Mark A. Dawson - Nature Reviews Molecular Cell Biology 2019 cited by 585

  8. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Authors: Mark A. Dawson, Rab K. Prinjha, Antje Dittmann, George Giotopoulos, Marcus Bantscheff, Wai-In Chan, Samuel C. Robson, Chun‐wa Chung, Carsten Hopf, Mikhail M. Savitski, Carola Huthmacher, Emma Gudgin, Dave Lugo, Sören Beinke, Trevor Chapman, Emma J. Roberts, Peter E. Soden, Kurt R. Auger, Olivier Mirguet, Konstanze Doehner, Ruud Delwel, Alan K. Burnett, Philip D. Jeffrey, Gerard Drewes, Kevin Lee, Brian J.P. Huntly, Tony Kouzarides - Nature 2011 cited by 1,532

  9. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

    Authors: Omer Gilan, Inmaculada Rioja, Kathy Knezevic, Matthew Bell, Miriam M. Yeung, Nicola Harker, Enid Y.N. Lam, Chun‐wa Chung, Paul Bamborough, M. Petretich, Marjeta Urh, Stephen J. Atkinson, Anna K. Bassil, Emma J. Roberts, Dane Vassiliadis, Marian L. Burr, Alex Preston, Christopher R. Wellaway, Thilo Werner, James R. Gray, Anne‐Marie Michon, Thomas Gobbetti, Vinod Kumar, Peter E. Soden, Andrea Haynes, Johanna Vappiani, David F. Tough, S. Taylor, Sarah‐Jane Dawson, Marcus Bantscheff, Matthew Lindon, Gerard Drewes, Emmanuel H. Demont, Danette L. Daniels, Paola Grandi, Rab K. Prinjha, Mark A. Dawson - Science 2020 cited by 428

  10. Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity

    Authors: Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, Wesley Blackaby, David Hardick, Yih-Chih Chan, Ali Motazedian, Andrea Gillespie, Dane Vassiliadis, Enid Y.N. Lam, Kevin Tran, Byron Andrews, Michael E. Harbour, Lina Vasiliauskaitė, Claire J. Saunders, Georgia Tsagkogeorga, Aleksandra Azevedo, Joanna Obacz, Ewa S. Pilka, Marie Carkill, Laura MacPherson, Elanor N. Wainwright, Brian Liddicoat, Benjamin J. Blyth, Mark R. Albertella, Oliver Rausch, Mark A. Dawson - Cancer Discovery 2023 cited by 115

  11. Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

    Authors: Lavinia Tan, Shahneen Sandhu, Rebecca Lee, James Li, Jason Callahan, Sarah Ftouni, Nathalie Dhomen, Philippa Middlehurst, Andrea Wallace, Jeanette Raleigh, Athena Hatzimihalis, Michael A. Henderson, Mark Shackleton, Andrew Haydon, Victoria Mar, David Gyorki, D. Oudit, Mark A. Dawson, Rodney J. Hicks, Paul Lorigan, Grant A. McArthur, Richard Marais, Stephen Q. Wong, Sarah‐Jane Dawson - Annals of Oncology 2019 cited by 190

  12. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells

    Authors: Iva A. Tchasovnikarova, Richard T. Timms, Nicholas J. Matheson, Kim Wals, Robin Antrobus, Berthold Göttgens, Gordon Dougan, Mark A. Dawson, Paul J. Lehner - Science 2015 cited by 372

  13. Non-genetic determinants of malignant clonal fitness at single-cell resolution

    Authors: Katie Fennell, Dane Vassiliadis, Enid Y.N. Lam, Luciano G. Martelotto, Jesse J. Balic, Sebastian Hollizeck, Tom Weber, Timothy Semple, Qing Wang, Denise C. Miles, Laura MacPherson, Yih-Chih Chan, Andrew A. Guirguis, Lev M. Kats, Emily Wong, Sarah‐Jane Dawson, Shalin H. Naik, Mark A. Dawson - Nature 2021 cited by 160

  14. HBO1 is required for the maintenance of leukaemia stem cells

    Authors: Laura MacPherson, Juliana Anokye, Miriam M. Yeung, Enid Y.N. Lam, Yih-Chih Chan, Chen-Fang Weng, Paul Yeh, Kathy Knezevic, Miriam Butler, Annabelle Hoegl, Kah Lok Chan, Marian L. Burr, Linden J. Gearing, Tracy A. Willson, Joy Liu, Jarny Choi, Yuqing Yang, Rebecca A. Bilardi, Hendrik Falk, Nghi Nguyen, Paul A. Stupple, Thomas S. Peat, Ming Zhang, Melanie de Silva, Catalina Carrasco‐Pozo, Vicky M. Avery, Poh Sim Khoo, Olan Dolezal, Matthew L. Dennis, Stewart D. Nuttall, Regina Surjadi, Janet Newman, Bin Ren, David J. Leaver, Yuxin Sun, Jonathan B. Baell, Oliver M. Dovey, George S. Vassiliou, Florian Grebien, Sarah‐Jane Dawson, Ian P. Street, Brendon J. Monahan, Christopher J. Burns, Chunaram Choudhary, Marnie E. Blewitt, Anne K. Voss, Tim Thomas, Mark A. Dawson - Nature 2019 cited by 174

  15. BET inhibitor resistance emerges from leukaemia stem cells

    Authors: Chun Yew Fong, Omer Gilan, Enid Y.N. Lam, Alan F. Rubin, Sarah Ftouni, Dean Tyler, Kym L. Stanley, Devbarna Sinha, Paul Yeh, Jessica Morison, George Giotopoulos, Dave Lugo, Philip Jeffrey, Stanley Chun-Wei Lee, Christopher Carpenter, Richard Gregory, Robert G. Ramsay, Steven Lane, Omar Abdel‐Wahab, Tony Kouzarides, Ricky W. Johnstone, Sarah‐Jane Dawson, Brian J.P. Huntly, Rab K. Prinjha, Anthony T. Papenfuss, Mark A. Dawson - Nature 2015 cited by 548

  16. The Epigenetic Hallmarks of Cancer

    Authors: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin - Cancer Discovery 2024 cited by 133

  17. The cancer epigenome: Concepts, challenges, and therapeutic opportunities

    Authors: Mark A. Dawson - Science 2017 cited by 380

  18. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

    Authors: Shikhar Sharma, Chi‐Yeh Chung, Sean Uryu, Jelena Petrovic, Joan Cao, Amanda J. Rickard, Nataliya Nady, S.E. Greasley, Eric F. Johnson, Oleg Brodsky, Showkhin Khan, Hui Wang, Zhenxiong Wang, Yong Zhang, Konstantinos Tsaparikos, Lei Chen, Anthony Mazurek, John D. Lapek, Pei‐Pei Kung, Scott C. Sutton, Paul Richardson, Eric C. Greenwald, Shinji Yamazaki, Rhys Jones, Karen A. Maegley, Patrick Bingham, Hieu Lam, Alexandra E. Stupple, Aileen Kamal, Anderly C. Chüeh, Anthony N. Cuzzupe, Benjamin J. Morrow, Bin Ren, Catalina Carrasco‐Pozo, Chin Wee Tan, Dharmesh D. Bhuva, Elizabeth Allan, Elliot Surgenor, François Vaillant, Havva Pehlivanoglu, Hendrik Falk, James R. Whittle, Janet Newman, Joseph Cursons, Judy P. Doherty, Karen L. White, Laura MacPherson, Mark Devlin, Matthew L. Dennis, Meghan Hattarki, Melanie de Silva, Michelle A. Camerino, Miriam Butler, Olan Dolezal, Patricia A. Pilling, Richard C. Foitzik, Paul A. Stupple, H. Rachel Lagiakos, Scott R. Walker, Soroor Hediyeh-zadeh, Stewart D. Nuttall, Sukhdeep K. Spall, Susan A. Charman, Theresa Connor, Thomas S. Peat, Vicky M. Avery, Ylva E. Bozikis, Yuqing Yang, Ming Zhang, Brendon J. Monahan, Anne K. Voss, Tim Thomas, Ian P. Street, Sarah‐Jane Dawson, Mark A. Dawson, Geoffrey J. Lindeman, Melissa J. Davis, Jane E. Visvader, Thomas A. Paul - Cell chemical biology 2023 cited by 69

  19. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS

    Authors: Rachel Deplus, Benjamin Delatte, Marie K. Schwinn, Matthieu Defrance, Jacqui Méndez, Nancy E. Murphy, Mark A. Dawson, Michael Volkmar, Pascale Putmans, Emilie Calonne, Alan H. Shih, Ross L. Levine, Olivier Bernard, Thomas Mercher, Éric Solary, Marjeta Urh, Danette L. Daniels, François Fuks - The EMBO Journal 2013 cited by 489

  20. Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

    Authors: Rishu Agarwal, Yih-Chih Chan, Constantine S. Tam, Tane Hunter, Dane Vassiliadis, Charis E. Teh, Rachel Thijssen, Paul Yeh, Stephen Q. Wong, Sarah Ftouni, Enid Y.N. Lam, Mary Ann Anderson, Christiane Pott, Omer Gilan, Charles C. Bell, Kathy Knezevic, Piers Blombery, Kathleen C. Rayeroux, Adrian Zordan, Jason Li, David C.S. Huang, Meaghan Wall, John F. Seymour, Daniel H.D. Gray, Andrew W. Roberts, Mark A. Dawson, Sarah‐Jane Dawson - Nature Medicine 2018 cited by 204

  21. Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia

    Authors: Özgen Deniz, Mamataz Ahmed, Christopher D Todd, Ana Rio‐Machín, Mark A. Dawson, Miguel R. Branco - Nature Communications 2020 cited by 149

  22. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

    Authors: Charles C. Bell, Katie Fennell, Yih-Chih Chan, Florian Rambow, Miriam M. Yeung, Dane Vassiliadis, Luis E. Lara Gonzalez, Paul Yeh, Luciano G. Martelotto, Aljosja Rogiers, Brandon E. Kremer, Olena Barbash, Helai P. Mohammad, Timothy M. Johanson, Marian L. Burr, Arindam Dhar, Natalie O. Karpinich, Luyi Tian, Dean Tyler, Laura MacPherson, Junwei Shi, Nathan Pinnawala, Chun Yew Fong, Anthony T. Papenfuss, Sean M. Grimmond, Sarah‐Jane Dawson, Rhys S. Allan, Ryan G. Kruger, Christopher R. Vakoc, David L. Goode, Shalin H. Naik, Omer Gilan, Enid Y.N. Lam, Jean‐Christophe Marine, Rab K. Prinjha, Mark A. Dawson - Nature Communications 2019 cited by 180

  23. CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

    Authors: April C. Watt, Paloma Cejas, Molly J. DeCristo, Otto Metzger, Enid Y.N. Lam, Xintao Qiu, Haley BrinJones, Nikolas Kesten, Rhiannon Coulson, Alba Font‐Tello, Klothilda Lim, Raga Vadhi, Veerle W. Daniëls, Joan Montero, Len Taing, Clifford A. Meyer, Omer Gilan, Charles C. Bell, Keegan Korthauer, Claudia Giambartolomei, Bogdan Paşaniuc, Ji-Heui Seo, Matthew L. Freedman, X. Cynthia, Matthew J. Ellis, Ian E. Krop, Eric P. Winer, Anthony Letai, Myles Brown, Mark A. Dawson, Henry W. Long, Jean J. Zhao, Shom Goel - Nature Cancer 2020 cited by 110

  24. Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes

    Authors: Christina E. Sparbier, Andrea Gillespie, Juliana Gomez, Nishi Kumari, Ali Motazedian, Kah Lok Chan, Charles C. Bell, Omer Gilan, Yih-Chih Chan, Sarah Popp, Daniel J. Gough, Mélanie Eckersley-Maslin, Sarah‐Jane Dawson, Paul J. Lehner, Kate D. Sutherland, Patricia Ernst, Gerard M. McGeehan, Enid Y.N. Lam, Marian L. Burr, Mark A. Dawson - Nature Cell Biology 2023 cited by 36